BLAIR DONALD W
CIK: 0001237789
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
DBX highlighted in Citi's top application software picks. Citi recently listed Dropbox among its top application‑software stocks, placing the company in a select group of software leaders. Another recent note highlighted that Dropbox’s stock has delivered returns that exceed the broader market over the same period. These mentions may draw investor attention as the company operates in a sector where large players such as Meta are expanding AI tools for small businesses.
Transaction History
| GLW | ▲ Buy | Option Exercise | 94 | $0 | 11/1/2024 | View on chart |
| GLW | ▲ Buy | Option Exercise | 163 | $0 | 11/1/2024 | View on chart |
| GLW | ▲ Buy | Option Exercise | 7,773 | $0 | 11/1/2024 | View on chart |
| GLW | ▲ Buy | Option Exercise | 9,500 | $0 | 11/1/2024 | View on chart |
| DBX | ▲ Buy | Grant | 10,478 | $0 | 5/16/2024 | View on chart |
| DBX | ▲ Buy | Grant | 11,077 | $0 | 5/18/2023 | View on chart |
| DBX | ▲ Buy | Grant | 12,297 | $0 | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Corning Faces Rating Downgrade Amid AI Risk Concerns
A recent Seeking Alpha report downgraded Corning, arguing the stock carries significant risk relative to its current valuation in the AI sector. This negative sentiment contrasts with other recent coverage highlighting Corning's new long-term deals in life sciences and its role in the growing cell culture market. The mixed narrative reflects a market weighing the company's strong fundamental partnerships against concerns about its high price-to-earnings ratio.
Corning Faces Rating Downgrade Amid AI Risk Concerns. A recent Seeking Alpha report downgraded Corning, arguing the stock carries significant risk relative to its current valuation in the AI sector. This negative sentiment contrasts with other recent coverage highlighting Corning's new long-term deals in life sciences and its role in the growing cell culture market. The mixed narrative reflects a market weighing the company's strong fundamental partnerships against concerns about its high price-to-earnings ratio.